BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
3/22/17 Utragenyx (RARE) Triheptanoin for Metabolic - General Subscribers Only Subscribers Only Subscribers Only
3/22/17 Novartis (NVS) Reasanz for Acute Decompensated Heart Failure Subscribers Only Subscribers Only Subscribers Only
3/22/17 Neuren (NEU:AU) NNZ-2566 for Rett Syndrome Subscribers Only Subscribers Only Subscribers Only
3/22/17 Sunesis (SNSS) Qinprezo for Acute Myelogenous Leukemia (AML) Subscribers Only Subscribers Only Subscribers Only
3/22/17 Shire (SHPG) SHP655 for Thrombotic Thrombocytopenic Purpura (TTP) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
03/23/17 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
03/23/17 Subscribers Only Subscribers Only Trial Data - Top-Line Results
03/23/17 Subscribers Only Subscribers Only Trial Data - Top-Line Results
03/23/17 Subscribers Only Subscribers Only Trial Data - Other
03/23/17 Subscribers Only Subscribers Only Trial Data - Updated Results